ALPHAMAB ONCOLOGYALPHAMAB ONCOLOGYALPHAMAB ONCOLOGY

ALPHAMAB ONCOLOGY

No trades
See on Supercharts

9966 fundamentals

An in-depth look to ALPHAMAB ONCOLOGY operating, investing, and financing activities

9966 free cash flow for H2 23 is -125.34 M HKD. For 2023, 9966 free cash flow was -212.98 M HKD and operating cash flow was -173 M HKD.

‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM
Free cash flowYoY growth